<DOC>
	<DOCNO>NCT00731900</DOCNO>
	<brief_summary>Topiramate ( TPM ) antiepileptic drug unique mode action often useful patient refractory drug . However use restrict high incidence cognitive adverse drug reaction ( ADRs ) associate TPM exposure . TPM show cause particular cognitive ADRs , characterize verbal fluency , attention , work memory language deficit , much high rate antiepileptic drug . There appear obvious difference patient experience cognitive ADRs TPM ( e.g . age , sex , concomitant medication , diagnosis ) , suggest genetic contributor .</brief_summary>
	<brief_title>Pharmacogenetic Study Topiramate-Induced Cognitive Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Cognition Disorders</mesh_term>
	<criteria>adult ( &gt; 17 year old ) patient epilepsy patient migraine treat topiramate allergy topiramate abnormal liver renal function</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>pharmacogenetic</keyword>
	<keyword>study</keyword>
	<keyword>Topirmate</keyword>
	<keyword>induced</keyword>
</DOC>